SEC Form D · Amendment · filed December 13, 2023
Reprise Biomedical, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (33)
Ronald Eibensteiner · Plymouth, MNDirectorPhil Nalbone · Plymouth, MNDirectorSteve Jagodzinski · Plymouth, MNExecJerrod Krueger · Plymouth, MNExecTina Walters · Plymouth, MNExecCarrie Powers · Plymouth, MNExec · DirectorHeather Kotila · Plymouth, MNExecHoward Root · Plymouth, MNDirectorJake Isenburg · Plymouth, MNExecGreg Smock · Plymouth, MNExecErwin Kelen · Plymouth, MNDirectorSteve Jagodzinski · Plymouth, MNExecErwin Kelen · Plymouth, MNDirectorCarrie Powers · Plymouth, MNExec · DirectorHoward Root · Plymouth, MNDirectorGreg Smock · Plymouth, MNExecPhil Nalbone · Plymouth, MNDirectorJerrod Krueger · Plymouth, MNExecTina Walters · Plymouth, MNExecRonald Eibensteiner · Plymouth, MNDirectorHeather Kotila · Plymouth, MNExecJake Isenburg · Plymouth, MNExecE. Brian Harvey · UPTON, MADirectorJoann Harris · Fort Worth, TXExecSteven A. Willmann · Fort Worth, TXExecJordan A. Kolar · Fort Worth, TXDirectorBradford Berenson · Fort Worth, TXExecNadia A. Karkar · Fort Worth, TXExecDaniel Friedland · DALLAS, TXDirectorKevin Lutz · San Francisco, CAExecVenkatesh Yerramsetty · FLOWER MOUND, TXExec · DirectorRyan Mcdermott · San Francisco, CAExecAndrew Osher · San Francisco, CADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗